Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition

Core Insights - Tandem Diabetes Care, Inc. (TNDM) exceeded expectations in Q4 '25 with a GAAP EPS of -$0.01, which was $0.05 above consensus estimates [1] - The company's revenue for the quarter reached $290.4 million, representing a year-over-year increase of approximately 2.8% and exceeding forecasts by $13.16 million [1] Financial Performance - GAAP EPS for Q4 '25 was -$0.01, surpassing the consensus by $0.05 [1] - Revenue for the quarter was $290.4 million, up 2.8% year-over-year and $13.16 million above forecasts [1]